We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRN
3726
DELISTED
Veren
VRN
$900 ﹤0.01%
110
LXEH
3727
Lixiang Education Holding
LXEH
$3.28M
$891 ﹤0.01%
22
API
3728
Agora
API
$377M
$878 ﹤0.01%
350
DRRX
3729
DELISTED
DURECT Corp
DRRX
$858 ﹤0.01%
710
OMIC
3730
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$854 ﹤0.01%
55
WKEY
3731
WISeKey
WKEY
$74M
$840 ﹤0.01%
338
ANTX icon
3732
AN2 Therapeutics
ANTX
$214M
$812 ﹤0.01%
250
BDRX
3733
Biodexa Pharmaceuticals
BDRX
$1.58M
0
TFII icon
3734
TFI International
TFII
$11.5B
$797 ﹤0.01%
5
ASLN
3735
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$794 ﹤0.01%
162
SPRO icon
3736
Spero Therapeutics
SPRO
$73M
$787 ﹤0.01%
458
SOHO
3737
DELISTED
Sotherly Hotels
SOHO
$772 ﹤0.01%
533
TCRT icon
3738
Alaunos Therapeutics
TCRT
$4.86M
$766 ﹤0.01%
42
TRIB
3739
Trinity Biotech
TRIB
$8.39M
$761 ﹤0.01%
12
HLTH
3740
DELISTED
Cue Health Inc. Common Stock
HLTH
$760 ﹤0.01%
4,022
BFRA
3741
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$714 ﹤0.01%
288
AMTD
3742
AMTD IDEA Group
AMTD
$72.6M
$704 ﹤0.01%
398
IMO icon
3743
Imperial Oil
IMO
$60.4B
$691 ﹤0.01%
10
CTRN icon
3744
Citi Trends
CTRN
$605M
$678 ﹤0.01%
25
CLS icon
3745
Celestica
CLS
$36.5B
$674 ﹤0.01%
15
ATER icon
3746
Aterian
ATER
$5.37M
$662 ﹤0.01%
240
XOS icon
3747
Xos
XOS
$37.7M
$654 ﹤0.01%
+64
New +$601
SAND
3748
DELISTED
Sandstorm Gold
SAND
$645 ﹤0.01%
123
VET icon
3749
Vermilion Energy
VET
$1.66B
$622 ﹤0.01%
50
ABCL icon
3750
AbCellera Biologics
ABCL
$2.12B
$611 ﹤0.01%
+135
New +$689

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.